Arachidonoyl ethanolamide phosphate

Arachidonoyl ethanolamide phosphate, an endocannabinoid, is an endogenous ligand for cannabinoid receptors in the central nervous system (CB1 subtype) and peripheral immune cells (CB2 subtype) [1][2].

Product Specifications

CAS Number

[183323-26-4]

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Apoptosis; Cannabinoid Receptor

Type

Natural Products

Related Pathways

Apoptosis; GPCR/G Protein; Neuronal Signaling

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/arachidonoyl-ethanolamide-phosphate.html

Concentration

2.34 mM * 1 mL in Ethanol

Purity

99.9

Solubility

10 mM in DMSO

Smiles

CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(NCCOP(O)(O)=O)=O

Molecular Formula

C22H38NO5P

Molecular Weight

427.51

Precautions

H302, H315, H319, H335

References & Citations

[1]M Maccarrone, et al. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem. 2000 Oct 13;275 (41) :31938-45.|[2]S O Jacobsson, et al. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J Pharmacol Exp Ther. 2001 Dec;299 (3) :951-9.